DNER and cancer: Although HMBA was likely the first anti-cancer compound used in the clinic that inhibited BET bromodomain proteins, the concept of BET inhibitors (BETis) were largely popularized with the development of the low nanomolar BETis JQ1 and iBET-151 [7,8].